Table 4 Comparison of patients with diabetic peripheral neuropathy between Mongolian population and Han population

Diabetes duration (month)

150.73 ± 94.24

148.43 ± 91.00

-0.082^a

0.935

Gender (male/female)

8/7

26/11

1.353^c

0.245

Age (years)

61.00 (54.00,68.00)

58.00 (54.00,64.00)

-0.920^b

0.357

Smoke (yes/no)

6/9

16/21

0.046^c

0.830

Drink (yes/no)

3/12

22/15

6.657^c

0.010

Waist circumference (cm)

96.00 (88.00,100.00)

93.00 (88.00,99.00)

-0.162^b

0.871

BMI (kg/m²)

25.50 (24.60,27.00)

26.10 (24.30,27.70)

-0.364^b

0.716

MALB (mg/L)

11.10 (5.90,23.20)

8.00 (3.40,15.95)

-1.050^b

0.294

HbA1c (%)

9.30 (8.20,10.70)

7.90 (7.05,8.90)

-2.264^b

0.024

ALT (U/L)

21.00 (15.00,26.00)

18.00 (12.00,26.50)

-0.668^b

0.504

AST (U/L)

20.00 (16.00,21.00)

17.00 (14.00,22.00)

-0.699^b

0.485

GGT (U/L)

24.00 (16.00,45.00)

24.00 (19.50,38.00)

-0.374^b

0.708

FPG (mmol/L)

8.54 ± 3.92

7.47 ± 2.42

-0.988^a

0.336

CREA (umol/L)

63.00 (48.90,71.00)

65.60 (52.10,73.75)

0.333^b

0.739

UA (umol/L)

312.93 ± 89.91

346.51 ± 92.68

1.194^a

0.238

CHOL (mmol/L)

4.45 (3.94,5.42)

4.36 (3.64,5.32)

-0.525^b

0.599

TG (mmol/L)

2.10 (1.40,3.40)

1.50 (1.10,2.06)

-1.546^b

0.122

HDL-C (mmol/L)

1.12 (0.91,1.25)

0.98 (0.87,1.14)

-1.192^b

0.233

CNFD (no./mm²)

18.91 ± 5.78

23.78 ± 7.84

2.173^a

0.035

CNBD (no./mm²)

20.00 (13.74,24.99)

30.00 (18.12,49.37)

-2.101^b

0.036

CNFL (mm/mm²)

13.01 ± 3.14

15.06 ± 3.67

1.897^a

0.064